Global Zika Virus Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Zika Virus Vaccines Industry Forecast” looks at past sales and reviews total world Zika Virus Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Zika Virus Vaccines sales for 2023 through 2029. With Zika Virus Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Zika Virus Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Zika Virus Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Zika Virus Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Zika Virus Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Zika Virus Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Zika Virus Vaccines.
The global Zika Virus Vaccines market size is projected to grow from US$ 12760 million in 2022 to US$ 15710 million in 2029; it is expected to grow at a CAGR of 15710 from 2023 to 2029.
United States market for Zika Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Zika Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Zika Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Zika Virus Vaccines players cover NHI, Sanofi, GSK, Bharat., Takeda, Inovio Pharmaceuticals, GeneOne Life Science Inc, PaxVax and Gilead Sciences Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Zika Virus Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Zika Virus Vaccines market?
What factors are driving Zika Virus Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Zika Virus Vaccines market opportunities vary by end market size?
How does Zika Virus Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Zika Virus Vaccines Industry Forecast” looks at past sales and reviews total world Zika Virus Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Zika Virus Vaccines sales for 2023 through 2029. With Zika Virus Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Zika Virus Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Zika Virus Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Zika Virus Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Zika Virus Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Zika Virus Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Zika Virus Vaccines.
The global Zika Virus Vaccines market size is projected to grow from US$ 12760 million in 2022 to US$ 15710 million in 2029; it is expected to grow at a CAGR of 15710 from 2023 to 2029.
United States market for Zika Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Zika Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Zika Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Zika Virus Vaccines players cover NHI, Sanofi, GSK, Bharat., Takeda, Inovio Pharmaceuticals, GeneOne Life Science Inc, PaxVax and Gilead Sciences Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Zika Virus Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- DNA Vaccine
- Inactivated Vaccine
- Purified Inactivated Vaccine
- Table of Contents
- Hospitals
- Clinics
- Academic and Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NHI
- Sanofi
- GSK
- Bharat.
- Takeda
- Inovio Pharmaceuticals
- GeneOne Life Science Inc
- PaxVax
- Gilead Sciences Inc.
- Intrexon Corp.
- NewLink Genetics Corp
What is the 10-year outlook for the global Zika Virus Vaccines market?
What factors are driving Zika Virus Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Zika Virus Vaccines market opportunities vary by end market size?
How does Zika Virus Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Zika Virus Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Zika Virus Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Zika Virus Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Zika Virus Vaccines Segment by Type
2.2.1 DNA Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Purified Inactivated Vaccine
2.2.4 Table of Contents
2.3 Zika Virus Vaccines Sales by Type
2.3.1 Global Zika Virus Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Zika Virus Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Zika Virus Vaccines Sale Price by Type (2018-2023)
2.4 Zika Virus Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Academic and Research
2.4.4 Others
2.5 Zika Virus Vaccines Sales by Application
2.5.1 Global Zika Virus Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Zika Virus Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Zika Virus Vaccines Sale Price by Application (2018-2023)
3 GLOBAL ZIKA VIRUS VACCINES BY COMPANY
3.1 Global Zika Virus Vaccines Breakdown Data by Company
3.1.1 Global Zika Virus Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Zika Virus Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Zika Virus Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Zika Virus Vaccines Revenue by Company (2018-2023)
3.2.2 Global Zika Virus Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Zika Virus Vaccines Sale Price by Company
3.4 Key Manufacturers Zika Virus Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Zika Virus Vaccines Product Location Distribution
3.4.2 Players Zika Virus Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ZIKA VIRUS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Zika Virus Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Zika Virus Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Zika Virus Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Zika Virus Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Zika Virus Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Zika Virus Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Zika Virus Vaccines Sales Growth
4.4 APAC Zika Virus Vaccines Sales Growth
4.5 Europe Zika Virus Vaccines Sales Growth
4.6 Middle East & Africa Zika Virus Vaccines Sales Growth
5 AMERICAS
5.1 Americas Zika Virus Vaccines Sales by Country
5.1.1 Americas Zika Virus Vaccines Sales by Country (2018-2023)
5.1.2 Americas Zika Virus Vaccines Revenue by Country (2018-2023)
5.2 Americas Zika Virus Vaccines Sales by Type
5.3 Americas Zika Virus Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Zika Virus Vaccines Sales by Region
6.1.1 APAC Zika Virus Vaccines Sales by Region (2018-2023)
6.1.2 APAC Zika Virus Vaccines Revenue by Region (2018-2023)
6.2 APAC Zika Virus Vaccines Sales by Type
6.3 APAC Zika Virus Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Zika Virus Vaccines by Country
7.1.1 Europe Zika Virus Vaccines Sales by Country (2018-2023)
7.1.2 Europe Zika Virus Vaccines Revenue by Country (2018-2023)
7.2 Europe Zika Virus Vaccines Sales by Type
7.3 Europe Zika Virus Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Zika Virus Vaccines by Country
8.1.1 Middle East & Africa Zika Virus Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Zika Virus Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Zika Virus Vaccines Sales by Type
8.3 Middle East & Africa Zika Virus Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Zika Virus Vaccines
10.3 Manufacturing Process Analysis of Zika Virus Vaccines
10.4 Industry Chain Structure of Zika Virus Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Zika Virus Vaccines Distributors
11.3 Zika Virus Vaccines Customer
12 WORLD FORECAST REVIEW FOR ZIKA VIRUS VACCINES BY GEOGRAPHIC REGION
12.1 Global Zika Virus Vaccines Market Size Forecast by Region
12.1.1 Global Zika Virus Vaccines Forecast by Region (2024-2029)
12.1.2 Global Zika Virus Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Zika Virus Vaccines Forecast by Type
12.7 Global Zika Virus Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 NHI
13.1.1 NHI Company Information
13.1.2 NHI Zika Virus Vaccines Product Portfolios and Specifications
13.1.3 NHI Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 NHI Main Business Overview
13.1.5 NHI Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Zika Virus Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Zika Virus Vaccines Product Portfolios and Specifications
13.3.3 GSK Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Bharat.
13.4.1 Bharat. Company Information
13.4.2 Bharat. Zika Virus Vaccines Product Portfolios and Specifications
13.4.3 Bharat. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bharat. Main Business Overview
13.4.5 Bharat. Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Zika Virus Vaccines Product Portfolios and Specifications
13.5.3 Takeda Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Inovio Pharmaceuticals
13.6.1 Inovio Pharmaceuticals Company Information
13.6.2 Inovio Pharmaceuticals Zika Virus Vaccines Product Portfolios and Specifications
13.6.3 Inovio Pharmaceuticals Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Inovio Pharmaceuticals Main Business Overview
13.6.5 Inovio Pharmaceuticals Latest Developments
13.7 GeneOne Life Science Inc
13.7.1 GeneOne Life Science Inc Company Information
13.7.2 GeneOne Life Science Inc Zika Virus Vaccines Product Portfolios and Specifications
13.7.3 GeneOne Life Science Inc Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GeneOne Life Science Inc Main Business Overview
13.7.5 GeneOne Life Science Inc Latest Developments
13.8 PaxVax
13.8.1 PaxVax Company Information
13.8.2 PaxVax Zika Virus Vaccines Product Portfolios and Specifications
13.8.3 PaxVax Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 PaxVax Main Business Overview
13.8.5 PaxVax Latest Developments
13.9 Gilead Sciences Inc.
13.9.1 Gilead Sciences Inc. Company Information
13.9.2 Gilead Sciences Inc. Zika Virus Vaccines Product Portfolios and Specifications
13.9.3 Gilead Sciences Inc. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Gilead Sciences Inc. Main Business Overview
13.9.5 Gilead Sciences Inc. Latest Developments
13.10 Intrexon Corp.
13.10.1 Intrexon Corp. Company Information
13.10.2 Intrexon Corp. Zika Virus Vaccines Product Portfolios and Specifications
13.10.3 Intrexon Corp. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Intrexon Corp. Main Business Overview
13.10.5 Intrexon Corp. Latest Developments
13.11 NewLink Genetics Corp
13.11.1 NewLink Genetics Corp Company Information
13.11.2 NewLink Genetics Corp Zika Virus Vaccines Product Portfolios and Specifications
13.11.3 NewLink Genetics Corp Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 NewLink Genetics Corp Main Business Overview
13.11.5 NewLink Genetics Corp Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Zika Virus Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Zika Virus Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Zika Virus Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Zika Virus Vaccines Segment by Type
2.2.1 DNA Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Purified Inactivated Vaccine
2.2.4 Table of Contents
2.3 Zika Virus Vaccines Sales by Type
2.3.1 Global Zika Virus Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Zika Virus Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Zika Virus Vaccines Sale Price by Type (2018-2023)
2.4 Zika Virus Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Academic and Research
2.4.4 Others
2.5 Zika Virus Vaccines Sales by Application
2.5.1 Global Zika Virus Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Zika Virus Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Zika Virus Vaccines Sale Price by Application (2018-2023)
3 GLOBAL ZIKA VIRUS VACCINES BY COMPANY
3.1 Global Zika Virus Vaccines Breakdown Data by Company
3.1.1 Global Zika Virus Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Zika Virus Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Zika Virus Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Zika Virus Vaccines Revenue by Company (2018-2023)
3.2.2 Global Zika Virus Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Zika Virus Vaccines Sale Price by Company
3.4 Key Manufacturers Zika Virus Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Zika Virus Vaccines Product Location Distribution
3.4.2 Players Zika Virus Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ZIKA VIRUS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Zika Virus Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Zika Virus Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Zika Virus Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Zika Virus Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Zika Virus Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Zika Virus Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Zika Virus Vaccines Sales Growth
4.4 APAC Zika Virus Vaccines Sales Growth
4.5 Europe Zika Virus Vaccines Sales Growth
4.6 Middle East & Africa Zika Virus Vaccines Sales Growth
5 AMERICAS
5.1 Americas Zika Virus Vaccines Sales by Country
5.1.1 Americas Zika Virus Vaccines Sales by Country (2018-2023)
5.1.2 Americas Zika Virus Vaccines Revenue by Country (2018-2023)
5.2 Americas Zika Virus Vaccines Sales by Type
5.3 Americas Zika Virus Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Zika Virus Vaccines Sales by Region
6.1.1 APAC Zika Virus Vaccines Sales by Region (2018-2023)
6.1.2 APAC Zika Virus Vaccines Revenue by Region (2018-2023)
6.2 APAC Zika Virus Vaccines Sales by Type
6.3 APAC Zika Virus Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Zika Virus Vaccines by Country
7.1.1 Europe Zika Virus Vaccines Sales by Country (2018-2023)
7.1.2 Europe Zika Virus Vaccines Revenue by Country (2018-2023)
7.2 Europe Zika Virus Vaccines Sales by Type
7.3 Europe Zika Virus Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Zika Virus Vaccines by Country
8.1.1 Middle East & Africa Zika Virus Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Zika Virus Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Zika Virus Vaccines Sales by Type
8.3 Middle East & Africa Zika Virus Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Zika Virus Vaccines
10.3 Manufacturing Process Analysis of Zika Virus Vaccines
10.4 Industry Chain Structure of Zika Virus Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Zika Virus Vaccines Distributors
11.3 Zika Virus Vaccines Customer
12 WORLD FORECAST REVIEW FOR ZIKA VIRUS VACCINES BY GEOGRAPHIC REGION
12.1 Global Zika Virus Vaccines Market Size Forecast by Region
12.1.1 Global Zika Virus Vaccines Forecast by Region (2024-2029)
12.1.2 Global Zika Virus Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Zika Virus Vaccines Forecast by Type
12.7 Global Zika Virus Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 NHI
13.1.1 NHI Company Information
13.1.2 NHI Zika Virus Vaccines Product Portfolios and Specifications
13.1.3 NHI Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 NHI Main Business Overview
13.1.5 NHI Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Zika Virus Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Zika Virus Vaccines Product Portfolios and Specifications
13.3.3 GSK Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Bharat.
13.4.1 Bharat. Company Information
13.4.2 Bharat. Zika Virus Vaccines Product Portfolios and Specifications
13.4.3 Bharat. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bharat. Main Business Overview
13.4.5 Bharat. Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Zika Virus Vaccines Product Portfolios and Specifications
13.5.3 Takeda Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Inovio Pharmaceuticals
13.6.1 Inovio Pharmaceuticals Company Information
13.6.2 Inovio Pharmaceuticals Zika Virus Vaccines Product Portfolios and Specifications
13.6.3 Inovio Pharmaceuticals Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Inovio Pharmaceuticals Main Business Overview
13.6.5 Inovio Pharmaceuticals Latest Developments
13.7 GeneOne Life Science Inc
13.7.1 GeneOne Life Science Inc Company Information
13.7.2 GeneOne Life Science Inc Zika Virus Vaccines Product Portfolios and Specifications
13.7.3 GeneOne Life Science Inc Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GeneOne Life Science Inc Main Business Overview
13.7.5 GeneOne Life Science Inc Latest Developments
13.8 PaxVax
13.8.1 PaxVax Company Information
13.8.2 PaxVax Zika Virus Vaccines Product Portfolios and Specifications
13.8.3 PaxVax Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 PaxVax Main Business Overview
13.8.5 PaxVax Latest Developments
13.9 Gilead Sciences Inc.
13.9.1 Gilead Sciences Inc. Company Information
13.9.2 Gilead Sciences Inc. Zika Virus Vaccines Product Portfolios and Specifications
13.9.3 Gilead Sciences Inc. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Gilead Sciences Inc. Main Business Overview
13.9.5 Gilead Sciences Inc. Latest Developments
13.10 Intrexon Corp.
13.10.1 Intrexon Corp. Company Information
13.10.2 Intrexon Corp. Zika Virus Vaccines Product Portfolios and Specifications
13.10.3 Intrexon Corp. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Intrexon Corp. Main Business Overview
13.10.5 Intrexon Corp. Latest Developments
13.11 NewLink Genetics Corp
13.11.1 NewLink Genetics Corp Company Information
13.11.2 NewLink Genetics Corp Zika Virus Vaccines Product Portfolios and Specifications
13.11.3 NewLink Genetics Corp Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 NewLink Genetics Corp Main Business Overview
13.11.5 NewLink Genetics Corp Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Zika Virus Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Zika Virus Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of DNA Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Major Players of Purified Inactivated Vaccine
Table 6. Major Players of Table of Contents
Table 7. Global Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 8. Global Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global Zika Virus Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global Zika Virus Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global Zika Virus Vaccines Sale Price by Type (2018-2023) & (USD/Kg)
Table 12. Global Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 13. Global Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global Zika Virus Vaccines Revenue by Application (2018-2023)
Table 15. Global Zika Virus Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global Zika Virus Vaccines Sale Price by Application (2018-2023) & (USD/Kg)
Table 17. Global Zika Virus Vaccines Sales by Company (2018-2023) & (MT)
Table 18. Global Zika Virus Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global Zika Virus Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Zika Virus Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global Zika Virus Vaccines Sale Price by Company (2018-2023) & (USD/Kg)
Table 22. Key Manufacturers Zika Virus Vaccines Producing Area Distribution and Sales Area
Table 23. Players Zika Virus Vaccines Products Offered
Table 24. Zika Virus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Zika Virus Vaccines Sales by Geographic Region (2018-2023) & (MT)
Table 28. Global Zika Virus Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global Zika Virus Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Zika Virus Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Zika Virus Vaccines Sales by Country/Region (2018-2023) & (MT)
Table 32. Global Zika Virus Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global Zika Virus Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Zika Virus Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Zika Virus Vaccines Sales by Country (2018-2023) & (MT)
Table 36. Americas Zika Virus Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas Zika Virus Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Zika Virus Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 40. Americas Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 41. APAC Zika Virus Vaccines Sales by Region (2018-2023) & (MT)
Table 42. APAC Zika Virus Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC Zika Virus Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Zika Virus Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 46. APAC Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 47. Europe Zika Virus Vaccines Sales by Country (2018-2023) & (MT)
Table 48. Europe Zika Virus Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe Zika Virus Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Zika Virus Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 52. Europe Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 53. Middle East & Africa Zika Virus Vaccines Sales by Country (2018-2023) & (MT)
Table 54. Middle East & Africa Zika Virus Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Zika Virus Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Zika Virus Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 58. Middle East & Africa Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 59. Key Market Drivers & Growth Opportunities of Zika Virus Vaccines
Table 60. Key Market Challenges & Risks of Zika Virus Vaccines
Table 61. Key Industry Trends of Zika Virus Vaccines
Table 62. Zika Virus Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Zika Virus Vaccines Distributors List
Table 65. Zika Virus Vaccines Customer List
Table 66. Global Zika Virus Vaccines Sales Forecast by Region (2024-2029) & (MT)
Table 67. Global Zika Virus Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Zika Virus Vaccines Sales Forecast by Country (2024-2029) & (MT)
Table 69. Americas Zika Virus Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Zika Virus Vaccines Sales Forecast by Region (2024-2029) & (MT)
Table 71. APAC Zika Virus Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Zika Virus Vaccines Sales Forecast by Country (2024-2029) & (MT)
Table 73. Europe Zika Virus Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Zika Virus Vaccines Sales Forecast by Country (2024-2029) & (MT)
Table 75. Middle East & Africa Zika Virus Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Zika Virus Vaccines Sales Forecast by Type (2024-2029) & (MT)
Table 77. Global Zika Virus Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Zika Virus Vaccines Sales Forecast by Application (2024-2029) & (MT)
Table 79. Global Zika Virus Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. NHI Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. NHI Zika Virus Vaccines Product Portfolios and Specifications
Table 82. NHI Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 83. NHI Main Business
Table 84. NHI Latest Developments
Table 85. Sanofi Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Zika Virus Vaccines Product Portfolios and Specifications
Table 87. Sanofi Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. GSK Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. GSK Zika Virus Vaccines Product Portfolios and Specifications
Table 92. GSK Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 93. GSK Main Business
Table 94. GSK Latest Developments
Table 95. Bharat. Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Bharat. Zika Virus Vaccines Product Portfolios and Specifications
Table 97. Bharat. Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 98. Bharat. Main Business
Table 99. Bharat. Latest Developments
Table 100. Takeda Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Takeda Zika Virus Vaccines Product Portfolios and Specifications
Table 102. Takeda Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 103. Takeda Main Business
Table 104. Takeda Latest Developments
Table 105. Inovio Pharmaceuticals Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Inovio Pharmaceuticals Zika Virus Vaccines Product Portfolios and Specifications
Table 107. Inovio Pharmaceuticals Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 108. Inovio Pharmaceuticals Main Business
Table 109. Inovio Pharmaceuticals Latest Developments
Table 110. GeneOne Life Science Inc Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. GeneOne Life Science Inc Zika Virus Vaccines Product Portfolios and Specifications
Table 112. GeneOne Life Science Inc Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 113. GeneOne Life Science Inc Main Business
Table 114. GeneOne Life Science Inc Latest Developments
Table 115. PaxVax Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. PaxVax Zika Virus Vaccines Product Portfolios and Specifications
Table 117. PaxVax Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 118. PaxVax Main Business
Table 119. PaxVax Latest Developments
Table 120. Gilead Sciences Inc. Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Gilead Sciences Inc. Zika Virus Vaccines Product Portfolios and Specifications
Table 122. Gilead Sciences Inc. Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 123. Gilead Sciences Inc. Main Business
Table 124. Gilead Sciences Inc. Latest Developments
Table 125. Intrexon Corp. Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Intrexon Corp. Zika Virus Vaccines Product Portfolios and Specifications
Table 127. Intrexon Corp. Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 128. Intrexon Corp. Main Business
Table 129. Intrexon Corp. Latest Developments
Table 130. NewLink Genetics Corp Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. NewLink Genetics Corp Zika Virus Vaccines Product Portfolios and Specifications
Table 132. NewLink Genetics Corp Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 133. NewLink Genetics Corp Main Business
Table 134. NewLink Genetics Corp Latest Developments
Table 1. Zika Virus Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Zika Virus Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of DNA Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Major Players of Purified Inactivated Vaccine
Table 6. Major Players of Table of Contents
Table 7. Global Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 8. Global Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global Zika Virus Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global Zika Virus Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global Zika Virus Vaccines Sale Price by Type (2018-2023) & (USD/Kg)
Table 12. Global Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 13. Global Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global Zika Virus Vaccines Revenue by Application (2018-2023)
Table 15. Global Zika Virus Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global Zika Virus Vaccines Sale Price by Application (2018-2023) & (USD/Kg)
Table 17. Global Zika Virus Vaccines Sales by Company (2018-2023) & (MT)
Table 18. Global Zika Virus Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global Zika Virus Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Zika Virus Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global Zika Virus Vaccines Sale Price by Company (2018-2023) & (USD/Kg)
Table 22. Key Manufacturers Zika Virus Vaccines Producing Area Distribution and Sales Area
Table 23. Players Zika Virus Vaccines Products Offered
Table 24. Zika Virus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Zika Virus Vaccines Sales by Geographic Region (2018-2023) & (MT)
Table 28. Global Zika Virus Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global Zika Virus Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Zika Virus Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Zika Virus Vaccines Sales by Country/Region (2018-2023) & (MT)
Table 32. Global Zika Virus Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global Zika Virus Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Zika Virus Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Zika Virus Vaccines Sales by Country (2018-2023) & (MT)
Table 36. Americas Zika Virus Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas Zika Virus Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Zika Virus Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 40. Americas Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 41. APAC Zika Virus Vaccines Sales by Region (2018-2023) & (MT)
Table 42. APAC Zika Virus Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC Zika Virus Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Zika Virus Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 46. APAC Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 47. Europe Zika Virus Vaccines Sales by Country (2018-2023) & (MT)
Table 48. Europe Zika Virus Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe Zika Virus Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Zika Virus Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 52. Europe Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 53. Middle East & Africa Zika Virus Vaccines Sales by Country (2018-2023) & (MT)
Table 54. Middle East & Africa Zika Virus Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Zika Virus Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Zika Virus Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Zika Virus Vaccines Sales by Type (2018-2023) & (MT)
Table 58. Middle East & Africa Zika Virus Vaccines Sales by Application (2018-2023) & (MT)
Table 59. Key Market Drivers & Growth Opportunities of Zika Virus Vaccines
Table 60. Key Market Challenges & Risks of Zika Virus Vaccines
Table 61. Key Industry Trends of Zika Virus Vaccines
Table 62. Zika Virus Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Zika Virus Vaccines Distributors List
Table 65. Zika Virus Vaccines Customer List
Table 66. Global Zika Virus Vaccines Sales Forecast by Region (2024-2029) & (MT)
Table 67. Global Zika Virus Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Zika Virus Vaccines Sales Forecast by Country (2024-2029) & (MT)
Table 69. Americas Zika Virus Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Zika Virus Vaccines Sales Forecast by Region (2024-2029) & (MT)
Table 71. APAC Zika Virus Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Zika Virus Vaccines Sales Forecast by Country (2024-2029) & (MT)
Table 73. Europe Zika Virus Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Zika Virus Vaccines Sales Forecast by Country (2024-2029) & (MT)
Table 75. Middle East & Africa Zika Virus Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Zika Virus Vaccines Sales Forecast by Type (2024-2029) & (MT)
Table 77. Global Zika Virus Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Zika Virus Vaccines Sales Forecast by Application (2024-2029) & (MT)
Table 79. Global Zika Virus Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. NHI Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. NHI Zika Virus Vaccines Product Portfolios and Specifications
Table 82. NHI Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 83. NHI Main Business
Table 84. NHI Latest Developments
Table 85. Sanofi Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Zika Virus Vaccines Product Portfolios and Specifications
Table 87. Sanofi Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. GSK Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. GSK Zika Virus Vaccines Product Portfolios and Specifications
Table 92. GSK Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 93. GSK Main Business
Table 94. GSK Latest Developments
Table 95. Bharat. Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Bharat. Zika Virus Vaccines Product Portfolios and Specifications
Table 97. Bharat. Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 98. Bharat. Main Business
Table 99. Bharat. Latest Developments
Table 100. Takeda Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Takeda Zika Virus Vaccines Product Portfolios and Specifications
Table 102. Takeda Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 103. Takeda Main Business
Table 104. Takeda Latest Developments
Table 105. Inovio Pharmaceuticals Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Inovio Pharmaceuticals Zika Virus Vaccines Product Portfolios and Specifications
Table 107. Inovio Pharmaceuticals Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 108. Inovio Pharmaceuticals Main Business
Table 109. Inovio Pharmaceuticals Latest Developments
Table 110. GeneOne Life Science Inc Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. GeneOne Life Science Inc Zika Virus Vaccines Product Portfolios and Specifications
Table 112. GeneOne Life Science Inc Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 113. GeneOne Life Science Inc Main Business
Table 114. GeneOne Life Science Inc Latest Developments
Table 115. PaxVax Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. PaxVax Zika Virus Vaccines Product Portfolios and Specifications
Table 117. PaxVax Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 118. PaxVax Main Business
Table 119. PaxVax Latest Developments
Table 120. Gilead Sciences Inc. Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Gilead Sciences Inc. Zika Virus Vaccines Product Portfolios and Specifications
Table 122. Gilead Sciences Inc. Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 123. Gilead Sciences Inc. Main Business
Table 124. Gilead Sciences Inc. Latest Developments
Table 125. Intrexon Corp. Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Intrexon Corp. Zika Virus Vaccines Product Portfolios and Specifications
Table 127. Intrexon Corp. Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 128. Intrexon Corp. Main Business
Table 129. Intrexon Corp. Latest Developments
Table 130. NewLink Genetics Corp Basic Information, Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. NewLink Genetics Corp Zika Virus Vaccines Product Portfolios and Specifications
Table 132. NewLink Genetics Corp Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 133. NewLink Genetics Corp Main Business
Table 134. NewLink Genetics Corp Latest Developments
LIST OF FIGURES
Figure 1. Picture of Zika Virus Vaccines
Figure 2. Zika Virus Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Zika Virus Vaccines Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Zika Virus Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Zika Virus Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of DNA Vaccine
Figure 10. Product Picture of Inactivated Vaccine
Figure 11. Product Picture of Purified Inactivated Vaccine
Figure 12. Product Picture of Table of Contents
Figure 13. Global Zika Virus Vaccines Sales Market Share by Type in 2022
Figure 14. Global Zika Virus Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. Zika Virus Vaccines Consumed in Hospitals
Figure 16. Global Zika Virus Vaccines Market: Hospitals (2018-2023) & (MT)
Figure 17. Zika Virus Vaccines Consumed in Clinics
Figure 18. Global Zika Virus Vaccines Market: Clinics (2018-2023) & (MT)
Figure 19. Zika Virus Vaccines Consumed in Academic and Research
Figure 20. Global Zika Virus Vaccines Market: Academic and Research (2018-2023) & (MT)
Figure 21. Zika Virus Vaccines Consumed in Others
Figure 22. Global Zika Virus Vaccines Market: Others (2018-2023) & (MT)
Figure 23. Global Zika Virus Vaccines Sales Market Share by Application (2022)
Figure 24. Global Zika Virus Vaccines Revenue Market Share by Application in 2022
Figure 25. Zika Virus Vaccines Sales Market by Company in 2022 (MT)
Figure 26. Global Zika Virus Vaccines Sales Market Share by Company in 2022
Figure 27. Zika Virus Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Zika Virus Vaccines Revenue Market Share by Company in 2022
Figure 29. Global Zika Virus Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Zika Virus Vaccines Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Zika Virus Vaccines Sales 2018-2023 (MT)
Figure 32. Americas Zika Virus Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. APAC Zika Virus Vaccines Sales 2018-2023 (MT)
Figure 34. APAC Zika Virus Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Europe Zika Virus Vaccines Sales 2018-2023 (MT)
Figure 36. Europe Zika Virus Vaccines Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Zika Virus Vaccines Sales 2018-2023 (MT)
Figure 38. Middle East & Africa Zika Virus Vaccines Revenue 2018-2023 ($ Millions)
Figure 39. Americas Zika Virus Vaccines Sales Market Share by Country in 2022
Figure 40. Americas Zika Virus Vaccines Revenue Market Share by Country in 2022
Figure 41. Americas Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Figure 42. Americas Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Figure 43. United States Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Zika Virus Vaccines Sales Market Share by Region in 2022
Figure 48. APAC Zika Virus Vaccines Revenue Market Share by Regions in 2022
Figure 49. APAC Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Figure 50. APAC Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Figure 51. China Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Zika Virus Vaccines Sales Market Share by Country in 2022
Figure 59. Europe Zika Virus Vaccines Revenue Market Share by Country in 2022
Figure 60. Europe Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Figure 61. Europe Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Figure 62. Germany Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Zika Virus Vaccines Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Zika Virus Vaccines Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Figure 71. Egypt Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Zika Virus Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Zika Virus Vaccines
Figure 78. Industry Chain Structure of Zika Virus Vaccines
Figure 79. Channels of Distribution
Figure 80. Global Zika Virus Vaccines Sales Market Forecast by Region (2024-2029)
Figure 81. Global Zika Virus Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Zika Virus Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Zika Virus Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Zika Virus Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Zika Virus Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Zika Virus Vaccines
Figure 2. Zika Virus Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Zika Virus Vaccines Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Zika Virus Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Zika Virus Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of DNA Vaccine
Figure 10. Product Picture of Inactivated Vaccine
Figure 11. Product Picture of Purified Inactivated Vaccine
Figure 12. Product Picture of Table of Contents
Figure 13. Global Zika Virus Vaccines Sales Market Share by Type in 2022
Figure 14. Global Zika Virus Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. Zika Virus Vaccines Consumed in Hospitals
Figure 16. Global Zika Virus Vaccines Market: Hospitals (2018-2023) & (MT)
Figure 17. Zika Virus Vaccines Consumed in Clinics
Figure 18. Global Zika Virus Vaccines Market: Clinics (2018-2023) & (MT)
Figure 19. Zika Virus Vaccines Consumed in Academic and Research
Figure 20. Global Zika Virus Vaccines Market: Academic and Research (2018-2023) & (MT)
Figure 21. Zika Virus Vaccines Consumed in Others
Figure 22. Global Zika Virus Vaccines Market: Others (2018-2023) & (MT)
Figure 23. Global Zika Virus Vaccines Sales Market Share by Application (2022)
Figure 24. Global Zika Virus Vaccines Revenue Market Share by Application in 2022
Figure 25. Zika Virus Vaccines Sales Market by Company in 2022 (MT)
Figure 26. Global Zika Virus Vaccines Sales Market Share by Company in 2022
Figure 27. Zika Virus Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Zika Virus Vaccines Revenue Market Share by Company in 2022
Figure 29. Global Zika Virus Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Zika Virus Vaccines Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Zika Virus Vaccines Sales 2018-2023 (MT)
Figure 32. Americas Zika Virus Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. APAC Zika Virus Vaccines Sales 2018-2023 (MT)
Figure 34. APAC Zika Virus Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Europe Zika Virus Vaccines Sales 2018-2023 (MT)
Figure 36. Europe Zika Virus Vaccines Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Zika Virus Vaccines Sales 2018-2023 (MT)
Figure 38. Middle East & Africa Zika Virus Vaccines Revenue 2018-2023 ($ Millions)
Figure 39. Americas Zika Virus Vaccines Sales Market Share by Country in 2022
Figure 40. Americas Zika Virus Vaccines Revenue Market Share by Country in 2022
Figure 41. Americas Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Figure 42. Americas Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Figure 43. United States Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Zika Virus Vaccines Sales Market Share by Region in 2022
Figure 48. APAC Zika Virus Vaccines Revenue Market Share by Regions in 2022
Figure 49. APAC Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Figure 50. APAC Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Figure 51. China Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Zika Virus Vaccines Sales Market Share by Country in 2022
Figure 59. Europe Zika Virus Vaccines Revenue Market Share by Country in 2022
Figure 60. Europe Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Figure 61. Europe Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Figure 62. Germany Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Zika Virus Vaccines Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Zika Virus Vaccines Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Zika Virus Vaccines Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Zika Virus Vaccines Sales Market Share by Application (2018-2023)
Figure 71. Egypt Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Zika Virus Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Zika Virus Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Zika Virus Vaccines
Figure 78. Industry Chain Structure of Zika Virus Vaccines
Figure 79. Channels of Distribution
Figure 80. Global Zika Virus Vaccines Sales Market Forecast by Region (2024-2029)
Figure 81. Global Zika Virus Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Zika Virus Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Zika Virus Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Zika Virus Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Zika Virus Vaccines Revenue Market Share Forecast by Application (2024-2029)
